Immunovant Inc. (IMVT) NASDAQ

$32.31 (0.21) (-0.65%)

Market Cap: $4.72B

As of 03/28/24 04:00 PM EDT. Market closed.

(IMVT)

Immunovant Inc. (IMVT)
NASDAQ

$32.31
(0.21) (-0.65%)

Market Cap: $4.72B

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

immunovant, inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. it develops imvt-1401, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in phase iia clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as ... read more

immunovant, inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. it develops imvt-1401, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in phase iia clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as has completed initiation of phase ii clinical trials for the treatment of warm autoimmune hemolytic anemia. the company is headquartered in new york, new york. immunovant, inc. is a subsidiary of roivant sciences ltd. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Full Time Employees
144
Address
.
PRICE CHART FOR IMMUNOVANT INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$32.66
Previous Close
$32.52
Days Range
$31.28 - $33.13
52 week range
$14.05 - $45.58
Volume
1,260,187
Avg. Volume (30 days)
1,316,507
Market Cap
$4.72B
Dividend Yield
-
P/E
-
Shares Outstanding
145,292,970
Open
$32.66
Previous Close
$32.52
Days Range
$31.28 - $33.13
52 week range
$14.05 - $45.58
Volume
1,260,187
Avg. Volume (30 days)
1,316,507
Market Cap
$4.72B
Dividend Yield
-
P/E
-
Shares Outstanding
145,292,970
FINANCIAL STATEMENTS FOR IMMUNOVANT INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR IMMUNOVANT INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Barnett Eva ReneeChief Financial OfficerFeb 22, 2024 Sale$36.152,930105,920320,420Feb 23, 2024, 04:21 PM
Levine Mark S.Chief Legal OfficerFeb 22, 2024 Sale$36.152,13477,144301,968Feb 23, 2024, 04:18 PM
Macias William L.Chief Medical OfficerFeb 22, 2024 Sale$36.152,22180,289330,952Feb 23, 2024, 04:16 PM
Butchko Julia G.Chief Development OfficerFeb 22, 2024 Sale$36.152,14677,578407,817Feb 23, 2024, 04:14 PM
Salzmann PeterChief Executive OfficerFeb 22, 2024 Sale$36.1513,454486,362931,231Feb 23, 2024, 04:11 PM
Levine Mark S.Chief Legal OfficerJan 26, 2024 Sale$37.923,027114,778304,148Jan 29, 2024, 04:12 PM
Geffner MichaelChief Medical OfficerJan 26, 2024 Sale$37.9210,101383,01290,052Jan 29, 2024, 04:11 PM
Macias William L.Chief Medical OfficerJan 18, 2024 Sale$41.0342417,397333,173Jan 19, 2024, 04:04 PM
Barnett Eva ReneeChief Financial OfficerJan 11, 2024 Sale$41.833,515147,023324,184Jan 12, 2024, 04:34 PM
Butchko Julia G.Chief Development OfficerJan 05, 2024 Sale$38.591,29750,051409,963Jan 09, 2024, 04:20 PM
Salzmann PeterChief Executive OfficerJan 05, 2024 Sale$38.593,824147,568944,685Jan 09, 2024, 04:18 PM
Fromkin Andrew J.DirectorDec 01, 2023 Sale$39.7312,350490,69797,067Dec 05, 2023, 04:30 PM
Pande AtulDirectorDec 01, 2023 Sale$39.7312,350490,66791,379Dec 05, 2023, 04:28 PM
MIGAUSKY GEORGE VDirectorDec 01, 2023 Sale$39.7312,700504,567118,308Dec 05, 2023, 04:25 PM
Salzmann PeterChief Executive OfficerNov 22, 2023 Sale$32.7816,217531,581949,125Nov 24, 2023, 02:55 PM
Barnett Eva ReneeChief Financial OfficerNov 22, 2023 Sale$32.784,055132,920327,019Nov 24, 2023, 02:51 PM
Butchko Julia G.Chief Development OfficerNov 22, 2023 Sale$32.783,265107,024411,384Nov 24, 2023, 02:47 PM
Macias William L.Chief Medical OfficerNov 22, 2023 Sale$32.783,265107,024333,721Nov 24, 2023, 02:45 PM
Levine Mark S.Chief Legal OfficerNov 22, 2023 Sale$32.783,252106,598307,253Nov 24, 2023, 02:41 PM
Levine Mark S.Chief Legal OfficerOct 25, 2023 Sale$34.664,107142,349310,381Oct 27, 2023, 04:04 PM
Macias William L.Chief Medical OfficerOct 19, 2023 Sale$36.8053019,504336,862Oct 20, 2023, 04:06 PM
Barnett Eva ReneeChief Financial OfficerOct 10, 2023 Sale$36.924,557168,244330,920Oct 11, 2023, 04:11 PM
Butchko Julia G.Chief Development OfficerOct 05, 2023 Sale$36.241,73562,885415,964Oct 06, 2023, 05:15 PM
Salzmann PeterChief Executive OfficerOct 05, 2023 Sale$36.245,239189,887969,071Oct 06, 2023, 05:10 PM
Roivant Sciences Ltd.DirectorOct 02, 2023 Option Exercise$38.004,473,684169,999,99278,279,015Oct 04, 2023, 05:15 PM
Roivant Sciences Ltd.DirectorOct 02, 2023 Buy$38.001,526,31658,000,00879,805,331Oct 04, 2023, 05:15 PM
Salzmann PeterChief Executive OfficerAug 30, 2023 Sale$22.0256,7741,250,338975,873Sep 01, 2023, 04:08 PM
Levine Mark S.Chief Legal OfficerAug 24, 2023 Sale$20.3012,286249,406314,489Aug 25, 2023, 05:05 PM
Barnett Eva ReneeChief Financial OfficerAug 24, 2023 Sale$20.3014,386292,036335,478Aug 25, 2023, 05:03 PM
Butchko Julia G.Chief Development OfficerAug 24, 2023 Sale$20.3012,333250,360416,261Aug 25, 2023, 05:00 PM
Macias William L.Chief Medical OfficerAug 24, 2023 Sale$20.3012,333250,360337,393Aug 25, 2023, 04:57 PM
Salzmann PeterChief Executive OfficerAug 14, 2023 Sale$21.42103,0582,207,1781,038,053Aug 16, 2023, 04:11 PM
Salzmann PeterChief Executive OfficerAug 07, 2023 Sale$21.73101,3392,202,0961,129,797Aug 08, 2023, 04:44 PM
Levine Mark S.Chief Legal OfficerJul 26, 2023 Sale$21.633,91784,725326,774Jul 27, 2023, 04:33 PM
Macias William L.Chief Medical OfficerJul 19, 2023 Sale$24.9442610,624349,725Jul 20, 2023, 04:37 PM
Barnett Eva ReneeChief Financial OfficerJul 19, 2023 Sale$24.942,72567,962349,863Jul 20, 2023, 04:35 PM
Salzmann PeterChief Executive OfficerJul 12, 2023 Sale$19.733,23363,7871,231,136Jul 13, 2023, 05:11 PM
Butchko Julia G.Chief Development OfficerJul 12, 2023 Sale$19.731,47029,003428,593Jul 13, 2023, 05:10 PM
Macias William L.Chief Medical OfficerApr 25, 2023 Sale$16.295098,292350,151Apr 26, 2023, 04:12 PM
Levine Mark S.Chief Legal OfficerApr 25, 2023 Sale$16.292,63342,892330,691Apr 26, 2023, 04:08 PM
Barnett Eva ReneeChief Financial OfficerApr 18, 2023 Sale$15.273,42352,269352,588Apr 19, 2023, 04:15 PM
Butchko Julia G.Chief Development OfficerApr 18, 2023 Sale$15.271,54423,577430,063Apr 19, 2023, 04:12 PM
Salzmann PeterChief Executive OfficerApr 18, 2023 Sale$15.273,39551,8421,234,369Apr 19, 2023, 04:09 PM
Macias William L.Chief Medical OfficerFeb 02, 2023 Sale$18.245379,795262,996Feb 03, 2023, 07:24 AM
Levine Mark S.Chief Legal OfficerJan 26, 2023 Sale$18.5110,156187,988245,660Jan 27, 2023, 07:20 AM
Salzmann PeterChief Executive OfficerJan 11, 2023 Sale$16.804,02167,553993,932Jan 13, 2023, 08:21 AM
Butchko Julia G.Chief Dev. & Tech. OfficerJan 11, 2023 Sale$16.7960,4901,015,596391,890Jan 13, 2023, 08:19 AM
Barnett Eva ReneeChief Financial OfficerJan 11, 2023 Sale$16.754,51075,525272,846Jan 13, 2023, 08:16 AM
Macias William L.Chief Medical OfficerJan 11, 2023 Sale$16.7544,568746,317307,981Jan 13, 2023, 08:13 AM
Macias William L.Chief Medical OfficerOct 21, 2022 Sale$9.673413,297308,101Oct 25, 2022, 07:43 AM
Butchko Julia G.Chief Dev. & Tech. OfficerOct 13, 2022 Sale$9.189288,519391,909Oct 17, 2022, 08:59 AM
Salzmann PeterChief Executive OfficerOct 13, 2022 Sale$9.182,79325,640997,953Oct 17, 2022, 08:57 AM
Barnett Eva ReneeChief Financial OfficerOct 11, 2022 Sale$9.4412,500118,000272,857Oct 13, 2022, 04:20 PM
Roivant Sciences Ltd.10% OwnerOct 06, 2022 Buy$6.00416,6672,500,00273,805,331Oct 07, 2022, 04:32 PM
Butchko Julia G.Chief Dev. & Tech. OfficerSep 28, 2022 Sale$4.675352,498392,837Sep 29, 2022, 05:09 PM
Salzmann PeterChief Executive OfficerSep 28, 2022 Sale$4.671,6057,4951,000,746Sep 29, 2022, 05:06 PM
Torti FrankDirectorSep 29, 2022 Buy$5.8120,000116,200393,358Sep 29, 2022, 04:21 PM
Salzmann PeterChief Executive OfficerAug 30, 2022 Sale$5.831,6449,5851,002,351Sep 01, 2022, 07:36 AM
Butchko Julia G.Chief Dev. & Tech. OfficerAug 30, 2022 Sale$5.835483,195393,372Sep 01, 2022, 07:33 AM
Butchko Julia G.Chief Dev. & Tech. OfficerJul 27, 2022 Sale$4.275102,178281,104Jul 29, 2022, 07:38 AM
Salzmann PeterChief Executive OfficerJul 27, 2022 Sale$4.271,5286,525552,731Jul 29, 2022, 07:36 AM
Macias William L.Chief Medical OfficerJul 22, 2022 Sale$4.703221,513195,626Jul 26, 2022, 07:35 AM
Salzmann PeterChief Executive OfficerJun 29, 2022 Sale$4.021,3765,532554,259Jul 01, 2022, 07:05 AM
Butchko Julia G.Chief Dev. & Tech. OfficerJun 29, 2022 Sale$4.024601,849281,614Jul 01, 2022, 07:04 AM
Butchko Julia G.Chief Dev. & Tech. OfficerMay 24, 2022 Sale$3.794921,865282,074May 25, 2022, 04:26 PM
Salzmann PeterChief Executive OfficerMay 24, 2022 Sale$3.791,4715,575555,635May 25, 2022, 04:23 PM
Butchko Julia G.Chief Dev. & Tech. OfficerApr 27, 2022 Sale$4.725412,554282,566Apr 29, 2022, 07:08 AM
Salzmann PeterChief Executive OfficerApr 27, 2022 Sale$4.721,6227,656557,106Apr 29, 2022, 07:05 AM
Macias William L.Chief Medical OfficerApr 19, 2022 Sale$4.981,3926,932195,948Apr 20, 2022, 04:34 PM
Butchko Julia G.Chief Dev. & Tech. OfficerMar 24, 2022 Sale$5.906,38137,648283,107Apr 14, 2022, 07:18 AM
Salzmann PeterChief Executive OfficerMar 24, 2022 Sale$5.9019,227113,439558,728Apr 14, 2022, 07:16 AM
Butchko Julia G.Chief Dev. & Tech. OfficerJan 07, 2022 Sale$7.2555,318401,056289,488Jan 11, 2022, 10:58 AM
Barnett Eva ReneeChief Financial OfficerJan 07, 2022 Sale$7.2529,959217,203172,541Jan 11, 2022, 10:53 AM
Salzmann PeterChief Executive OfficerJan 07, 2022 Sale$7.25125,158907,396577,955Jan 11, 2022, 10:49 AM
Macias William L.Chief Medical OfficerJan 05, 2022 Sale$8.2826,813222,012197,340Jan 07, 2022, 12:39 PM
Hughes Douglas J.DirectorAug 27, 2021 Buy$8.2418,247150,35558,447Aug 30, 2021, 09:08 AM
MIGAUSKY GEORGE VDirectorAug 20, 2021 Buy$7.657,00053,55067,200Aug 20, 2021, 06:14 PM
Pande AtulDirectorAug 13, 2021 Buy$7.985,00039,90045,200Aug 16, 2021, 05:29 PM
Fromkin Andrew J.DirectorAug 10, 2021 Buy$7.905,50043,45045,700Aug 11, 2021, 02:12 PM
Butchko Julia G.Chief Dev. & Tech. OfficerSep 11, 2020 Buy$38.175,000190,8505,000Sep 15, 2020, 05:09 PM
Roivant Sciences Ltd.10% OwnerSep 04, 2020 Buy$33.00380,00012,540,00047,593,419Sep 04, 2020, 05:29 PM
Roivant Sciences Ltd.10% OwnerApr 16, 2020 Buy$14.501,034,48315,000,00438,439,450Apr 17, 2020, 05:28 PM
Roivant Sciences Ltd.10% OwnerDec 18, 2019 Option Exercise$10.0036,919,967369,199,67037,404,967Dec 20, 2019, 05:28 PM
WONG RODERICKChief Executive OfficerDec 11, 2019 Buy$10.9231,500344,024902,498Dec 13, 2019, 06:00 PM
WONG RODERICKChief Executive OfficerDec 10, 2019 Buy$10.3825,971269,517870,998Dec 10, 2019, 06:22 PM
WONG RODERICKChief Executive OfficerDec 06, 2019 Buy$10.2050,000510,125845,027Dec 09, 2019, 05:01 PM
WONG RODERICKChief Executive OfficerDec 06, 2019 Buy$10.25400,0004,100,000795,027Dec 09, 2019, 07:31 AM
WONG RODERICKChief Executive OfficerDec 05, 2019 Buy$10.1520,000203,000395,027Dec 05, 2019, 06:07 PM
WONG RODERICKChief Executive OfficerDec 04, 2019 Buy$10.1520,000203,000375,027Dec 04, 2019, 06:33 PM
WONG RODERICKChief Executive OfficerDec 03, 2019 Buy$10.2120,000204,200355,027Dec 03, 2019, 05:42 PM
WONG RODERICKChief Executive OfficerDec 02, 2019 Buy$10.4020,000208,000335,027Dec 03, 2019, 05:42 PM
WONG RODERICKChief Executive OfficerNov 29, 2019 Buy$10.4526,918281,293315,027Dec 03, 2019, 05:42 PM
WONG RODERICKChief Executive OfficerNov 25, 2019 Buy$10.504,00042,000280,109Nov 29, 2019, 01:00 PM
WONG RODERICKChief Executive OfficerNov 27, 2019 Buy$10.484,00041,904288,109Nov 29, 2019, 01:00 PM
WONG RODERICKChief Executive OfficerNov 26, 2019 Buy$10.494,00041,960284,109Nov 29, 2019, 01:00 PM
WONG RODERICKChief Executive OfficerNov 22, 2019 Buy$10.542,00021,080276,109Nov 22, 2019, 05:42 PM
WONG RODERICKChief Executive OfficerNov 21, 2019 Buy$10.4215,194158,299274,109Nov 22, 2019, 05:42 PM
WONG RODERICKChief Executive OfficerNov 20, 2019 Buy$10.3929,805309,582258,915Nov 22, 2019, 05:42 PM
WONG RODERICKChief Executive OfficerNov 19, 2019 Buy$10.2529,805305,501229,110Nov 19, 2019, 06:06 PM
WONG RODERICKChief Executive OfficerNov 18, 2019 Buy$10.2529,805305,501199,305Nov 19, 2019, 06:06 PM
WONG RODERICKChief Executive OfficerNov 15, 2019 Buy$10.2913,000133,800169,500Nov 19, 2019, 06:06 PM
WONG RODERICKChief Executive OfficerNov 14, 2019 Buy$10.1713,000132,210156,500Nov 14, 2019, 05:51 PM
WONG RODERICKChief Executive OfficerNov 13, 2019 Buy$10.1713,000132,210143,500Nov 14, 2019, 05:51 PM
WONG RODERICKChief Executive OfficerNov 12, 2019 Buy$10.17100,0001,017,000130,500Nov 14, 2019, 05:51 PM
WONG RODERICKChief Executive OfficerNov 11, 2019 Buy$10.1813,000132,34030,500Nov 12, 2019, 06:59 AM
WONG RODERICKChief Executive OfficerNov 07, 2019 Buy$10.1817,500178,15017,500Nov 12, 2019, 06:59 AM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Barnett Eva ReneeChief Financial Officer02/22/2024105,920
Levine Mark S.Chief Legal Officer02/22/202477,144
Macias William L.Chief Medical Officer02/22/202480,289
Butchko Julia G.Chief Development Officer02/22/202477,578
Salzmann PeterChief Executive Officer02/22/2024486,362
Levine Mark S.Chief Legal Officer01/26/2024114,778
Geffner MichaelChief Medical Officer01/26/2024383,012
Macias William L.Chief Medical Officer01/18/202417,397
Barnett Eva ReneeChief Financial Officer01/11/2024147,023
Butchko Julia G.Chief Development Officer01/05/202450,051
Salzmann PeterChief Executive Officer01/05/2024147,568
Fromkin Andrew J.Director12/01/2023490,697
Pande AtulDirector12/01/2023490,667
MIGAUSKY GEORGE VDirector12/01/2023504,567
Salzmann PeterChief Executive Officer11/22/2023531,581
Barnett Eva ReneeChief Financial Officer11/22/2023132,920
Butchko Julia G.Chief Development Officer11/22/2023107,024
Macias William L.Chief Medical Officer11/22/2023107,024
Levine Mark S.Chief Legal Officer11/22/2023106,598
Levine Mark S.Chief Legal Officer10/25/2023142,349
Macias William L.Chief Medical Officer10/19/202319,504
Barnett Eva ReneeChief Financial Officer10/10/2023168,244
Butchko Julia G.Chief Development Officer10/05/202362,885
Salzmann PeterChief Executive Officer10/05/2023189,887
Roivant Sciences Ltd.Director10/02/2023169,999,992
Roivant Sciences Ltd.Director10/02/202358,000,008
Salzmann PeterChief Executive Officer08/30/20231,250,338
Levine Mark S.Chief Legal Officer08/24/2023249,406
Barnett Eva ReneeChief Financial Officer08/24/2023292,036
Butchko Julia G.Chief Development Officer08/24/2023250,360
Macias William L.Chief Medical Officer08/24/2023250,360
Salzmann PeterChief Executive Officer08/14/20232,207,178
Salzmann PeterChief Executive Officer08/07/20232,202,096
Levine Mark S.Chief Legal Officer07/26/202384,725
Macias William L.Chief Medical Officer07/19/202310,624
Barnett Eva ReneeChief Financial Officer07/19/202367,962
Salzmann PeterChief Executive Officer07/12/202363,787
Butchko Julia G.Chief Development Officer07/12/202329,003
Macias William L.Chief Medical Officer04/25/20238,292
Levine Mark S.Chief Legal Officer04/25/202342,892
Barnett Eva ReneeChief Financial Officer04/18/202352,269
Butchko Julia G.Chief Development Officer04/18/202323,577
Salzmann PeterChief Executive Officer04/18/202351,842
Macias William L.Chief Medical Officer02/02/20239,795
Levine Mark S.Chief Legal Officer01/26/2023187,988
Salzmann PeterChief Executive Officer01/11/202367,553
Butchko Julia G.Chief Dev. & Tech. Officer01/11/20231,015,596
Barnett Eva ReneeChief Financial Officer01/11/202375,525
Macias William L.Chief Medical Officer01/11/2023746,317
Macias William L.Chief Medical Officer10/21/20223,297
Butchko Julia G.Chief Dev. & Tech. Officer10/13/20228,519
Salzmann PeterChief Executive Officer10/13/202225,640
Barnett Eva ReneeChief Financial Officer10/11/2022118,000
Roivant Sciences Ltd.10% Owner10/06/20222,500,002
Butchko Julia G.Chief Dev. & Tech. Officer09/28/20222,498
Salzmann PeterChief Executive Officer09/28/20227,495
Torti FrankDirector09/29/2022116,200
Salzmann PeterChief Executive Officer08/30/20229,585
Butchko Julia G.Chief Dev. & Tech. Officer08/30/20223,195
Butchko Julia G.Chief Dev. & Tech. Officer07/27/20222,178
Salzmann PeterChief Executive Officer07/27/20226,525
Macias William L.Chief Medical Officer07/22/20221,513
Salzmann PeterChief Executive Officer06/29/20225,532
Butchko Julia G.Chief Dev. & Tech. Officer06/29/20221,849
Butchko Julia G.Chief Dev. & Tech. Officer05/24/20221,865
Salzmann PeterChief Executive Officer05/24/20225,575
Butchko Julia G.Chief Dev. & Tech. Officer04/27/20222,554
Salzmann PeterChief Executive Officer04/27/20227,656
Macias William L.Chief Medical Officer04/19/20226,932
Butchko Julia G.Chief Dev. & Tech. Officer03/24/202237,648
Salzmann PeterChief Executive Officer03/24/2022113,439
Butchko Julia G.Chief Dev. & Tech. Officer01/07/2022401,056
Barnett Eva ReneeChief Financial Officer01/07/2022217,203
Salzmann PeterChief Executive Officer01/07/2022907,396
Macias William L.Chief Medical Officer01/05/2022222,012
Hughes Douglas J.Director08/27/2021150,355
MIGAUSKY GEORGE VDirector08/20/202153,550
Pande AtulDirector08/13/202139,900
Fromkin Andrew J.Director08/10/202143,450
Butchko Julia G.Chief Dev. & Tech. Officer09/11/2020190,850
Roivant Sciences Ltd.10% Owner09/04/202012,540,000
Roivant Sciences Ltd.10% Owner04/16/202015,000,004
Roivant Sciences Ltd.10% Owner12/18/2019369,199,670
WONG RODERICKChief Executive Officer12/11/2019344,024
WONG RODERICKChief Executive Officer12/10/2019269,517
WONG RODERICKChief Executive Officer12/06/2019510,125
WONG RODERICKChief Executive Officer12/06/20194,100,000
WONG RODERICKChief Executive Officer12/05/2019203,000
WONG RODERICKChief Executive Officer12/04/2019203,000
WONG RODERICKChief Executive Officer12/03/2019204,200
WONG RODERICKChief Executive Officer12/02/2019208,000
WONG RODERICKChief Executive Officer11/29/2019281,293
WONG RODERICKChief Executive Officer11/25/201942,000
WONG RODERICKChief Executive Officer11/27/201941,904
WONG RODERICKChief Executive Officer11/26/201941,960
WONG RODERICKChief Executive Officer11/22/201921,080
WONG RODERICKChief Executive Officer11/21/2019158,299
WONG RODERICKChief Executive Officer11/20/2019309,582
WONG RODERICKChief Executive Officer11/19/2019305,501
WONG RODERICKChief Executive Officer11/18/2019305,501
WONG RODERICKChief Executive Officer11/15/2019133,800
WONG RODERICKChief Executive Officer11/14/2019132,210
WONG RODERICKChief Executive Officer11/13/2019132,210
WONG RODERICKChief Executive Officer11/12/20191,017,000
WONG RODERICKChief Executive Officer11/11/2019132,340
WONG RODERICKChief Executive Officer11/07/2019178,150
Load More Insider Transactions
FUNDS WITH A POSITION IN IMMUNOVANT INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.4,530,7160.00487%9.66%Other
ALPINE GLOBAL MANAGEMENT, LLC1,398,37218.84%11.65%Event Driven
ADAGE CAPITAL PARTNERS GP, L.L.C.1,331,7800.12%206.51%Other
GEODE CAPITAL MANAGEMENT, LLC1,272,9660.00561%11.24%Other
CAPITAL RESEARCH GLOBAL INVESTORS976,2370.01%30.16%Growth At A Reasonable Price
FARALLON CAPITAL MANAGEMENT LLC341,0000.07%-32.34%Event Driven, Value
BAKER BROS. ADVISORS LP425,0090.2%No changeOther
BALYASNY ASSET MANAGEMENT L.P.350,000 (Put)0.03%ExitedEvent Driven
PLATINUM INVESTMENT MANAGEMENT LTD228,7650.39%1.25%Growth At A Reasonable Price, Value
RENAISSANCE TECHNOLOGIES LLC18,3000.00119%-91.73%Other
SENATOR INVESTMENT GROUP LP175,0000.32%NewEvent Driven, Value
D. E. SHAW & CO., INC.55,9660.00206%-60.74%Other
SOROS FUND MANAGEMENT LLC140,0000.08%86.67%Other
WCM INVESTMENT MANAGEMENT, LLC107,4010.01%NewGrowth At A Reasonable Price
ALPS ADVISORS INC96,4340.03%ExitedOther
AQR CAPITAL MANAGEMENT LLC68,9640.00547%168.41%Other
BAMCO INC /NY/59,0000.00662%NewGrowth At A Reasonable Price
TUDOR INVESTMENT CORP ET AL38,3420.01%NewEvent Driven, Other
BALYASNY ASSET MANAGEMENT L.P.9,7830.00077%NewEvent Driven
GOTHAM ASSET MANAGEMENT, LLC5,5270.00438%ExitedOther
CHANGE IN SHARES OUTSTANDING FOR IMMUNOVANT INC
STOCK BUYBACKS FOR IMMUNOVANT INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
10.19%
1Q
12/31/2023
06/30/2023
10.74%
2Q
12/31/2023
03/31/2023
10.91%
3Q
12/31/2023
12/31/2022
12.40%
4Q
12/31/2023
09/30/2022
23.98%
5Q
12/31/2023
06/30/2022
23.99%
6Q
12/31/2023
03/31/2022
24.19%
7Q
12/31/2023
12/31/2021
25.64%
8Q
12/31/2023
09/30/2021
32.49%
9Q
12/31/2023
06/30/2021
47.51%
10Q
12/31/2023
03/31/2021
47.80%
11Q
12/31/2023
12/31/2020
47.59%
12Q
12/31/2023
09/30/2020
71.33%
13Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
10.19%
1Q
06/30/2023
10.74%
2Q
03/31/2023
10.91%
3Q
12/31/2022
12.40%
4Q
09/30/2022
23.98%
5Q
06/30/2022
23.99%
6Q
03/31/2022
24.19%
7Q
12/31/2021
25.64%
8Q
09/30/2021
32.49%
9Q
06/30/2021
47.51%
10Q
03/31/2021
47.80%
11Q
12/31/2020
47.59%
12Q
09/30/2020
71.33%
13Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR IMMUNOVANT INC
LOADING...